MediSave withdrawal limit for HIV drugs to go up from S$550 to S$850 monthly
To encourage testing, HIV self-testing kits have been made available at places such as some retail pharmacies since…
Healing the future: Traditional medicine drives innovation, equity and planetary health at WHA79
Traditional medicine (TM) was highlighted as a critical lever for global health transformation at the 79th World Health…
These five common medications make it harder to cope in the heat
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Meet Reta, the ‘Godzilla’ fat jab making Ozempic look lightweight
There’s a new weight-loss jab on the horizon, and it may mean bad news for the makers of…
Homeopathy effectiveness explained by physician
What science says about homeopathy
Despite loud promises of healing, these preparations often contain no molecule of…
Discharge medicines service: scaling success nationwide
The discharge medicines service (DMS), which involves hospital, GP, primary care network (PCN) and community pharmacy teams, can…
LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case
Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
Delhi High Court upholds order restraining Dabur from selling Cool King oil in Emami Navratna-like packaging
Emami approached the Court seeking an interim injunction against Dabur’s Cool King Thanda Tael, alleging that its trade…
Foundayo (orforglipron), a once-daily pill taken without food or water restrictions, was associated with reduced body weight of up to 13% in adults 65 and older with obesity or overweight, in new analysis of ATTAIN-1/2
Once-daily oral Foundayo was associated with statistically significant body weight reductions vs. placebo in adults ≥65 years at…
Where do Europeans wait longest for new medicines?
While medicines and novel therapies emerge and new treatments are being discovered, many medicines are still not equally…
From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Key Points Interested in Eli Lilly and Company? Here are five stocks we like better. Eli Lilly saw…
Pharmacists ‘can’t afford’ to keep providing blister packs of tablets
Smyth pointed out that in some cases, people don’t have family. “So what’s the answer? The answer to…